(Total Views: 510)
Posted On: 04/26/2022 9:33:45 AM
Post# of 157708
True but why move around COO and have an opening for CEO? Maybe a partnership to prove ourselves and then a buyout?
Once again I don’t see a buyout at all anytime soon. We need that BLA done and behind us before BP starts making offers. I guess you are right they won’t let us run at it alone in the long run but i most definitely do not see a buyout anytime soon. We need a solid trial with an approval.
It’s going to take a partnership with a huge cash infusion to get us there.
Once again I don’t see a buyout at all anytime soon. We need that BLA done and behind us before BP starts making offers. I guess you are right they won’t let us run at it alone in the long run but i most definitely do not see a buyout anytime soon. We need a solid trial with an approval.
It’s going to take a partnership with a huge cash infusion to get us there.
(1)
(0)
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
